Author:
D’Abundo Lucilla,Bassi Cristian,Callegari Elisa,Moshiri Farzaneh,Guerriero Paola,Michilli Angelo,Mora Fernanda,Gardini Andrea Casadei,Sangiovanni Angelo,Piscaglia Fabio,Sabbioni Silvia,Gramantieri Laura,Negrini Massimo
Funder
Università degli Studi di Ferrara
Ministero della Salute
Associazione Italiana per la Ricerca sul Cancro
European Programme H2020
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 7, 6. https://doi.org/10.1038/s41572-020-00240-3 (2021).
2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J. Clin. 65, 5–29. https://doi.org/10.3322/caac.21254 (2015).
3. Kulik, L. & El-Serag, H. B. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156, 477–491. https://doi.org/10.1053/j.gastro.2018.08.065 (2019).
4. Heidelbaugh, J. J. & Bruderly, M. Cirrhosis and chronic liver failure: Part I. Diagnosis and evaluation. Am. Family Physician 74, 756–762 (2006).
5. Sidali, S., Trepo, E., Sutter, O. & Nault, J. C. New concepts in the treatment of hepatocellular carcinoma. Unit. Eur. Gastroenterol. J. 10, 765–774. https://doi.org/10.1002/ueg2.12286 (2022).